CistromeFinder for ChIP-seq and DNase-seq data reuse
Hanfei Sun(Tongji University), X. Shirley Liu(Harbin Medical University), Prakash K. Rao(Dana-Farber Cancer Institute), Myles Brown(Harvard University), Qixuan Wang(Tongji University), Len Taing(Dana-Farber Cancer Institute), Xueqiu Lin(Stanford University), Henry W. Long(Dana-Farber Cancer Institute), Bo Qin(Tongji University), Tao Liu(PowerChina (China)), Juan Wang(Tongji University), Yu‐Lin Yang(Chung Hwa University of Medical Technology), Jing Liu(China University of Petroleum, Beijing), Yong Zhang(Shanghai East Hospital)
Cited by 17
Related Papers
Model-based Analysis of ChIP-Seq (MACS)
|Genome biology|2008|20k
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
|Genome biology|2016|2.8k
Identifying ChIP-seq enrichment using MACS
|Nature Protocols|2012|2.1k
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
|Journal of Clinical Investigation|2011|928
Cistrome: an integrative platform for transcriptional regulation studies
|Genome biology|2011|792